State Ledger
Company profile

AYTU BIOPHARMA, INC CIK 1385818

Ticker
AYTU (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Denver, CO 80237
Fiscal year end
2026 (FY)
Market Data
Close
$2.04
Change
-$0.07
Change %
-3.09%
Volume
276

AYTU · trading date Oct 12, 2026 · previous close $2.11 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$57.57M
Net income
-$14.25M
Total assets
$105.01M
Total liabilities
—
Stockholders' equity
$35.27M
Cash & equivalents
$26.31M
Operating income
-$8.32M
Operating cash flow
$3.28M
Capital expenditures
$29.0K

Fiscal year 2026, via 10-K filed 2026-09-22. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
-14.4%
Net margin
-24.8%
Free cash flow
$3.25M
Free cash flow margin
5.6%
Liabilities / assets
—
Equity / assets
33.6%
CapEx / revenue
0.1%
Operating cash flow / net income
-0.23×

Derived from the fiscal year 2026 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2026 $57.57M -$14.25M $105.01M — $35.27M
2025 $66.38M -$13.56M $124.18M — $18.97M
2024 $65.18M -$15.84M $118.10M — $27.72M
2023 $107.40M -$17.05M $136.46M $97.11M $39.36M
2022 $96.67M -$108.78M $137.62M $93.32M $44.31M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form SCHEDULE 13G/A
2026-08-14
Financials filed via
Form 10-K
filed 2026-09-22

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Denver, CO 80237
7900 E. UNION AVENUE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:21 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Colorado — Public Companies